Original article
Major genetic mechanisms in pulmonary function

https://doi.org/10.1016/0895-4356(90)90037-PGet rights and content

Abstract

Regresssive models were used to search for possible major gene effects on pulmonary function in two groups of families: one ascertained through patients with chronic obstructive pulmonary disease [COPD defined as forced expiratory volume in one second (FEV1) < 70% forced vital capacity (FVC)] and the other ascertained through patients with non-pulmonary disorders. There were 85 COPD families with data on 270 individuals and 56 non-pulmonary families with data on 199 individuals. The analysis was done on residuals obtained from a regression of FEV, on age, sex, race, height, and ascertainment group. Smoking status was incorporated directly as a covariate in the regressive models. Data on probands were excluded in this analysis as a partial correction for ascertainment bias.

The best fitting model for the 85 COPD families included a major gene effect with sex specific variances, but no residual familial correlation. The best fitting model for the non-pulmonary families was one with no major gene effect and no residual familial correlation. Cigarette smoking was a significant covariate in both groups of families. Testing for heterogeneity showed a significant difference in the control of pulmonary function among these COPD and non-pulmonary families (ξ2 = 20.12 on 6 df; p = 0.0026). Major gene effects appear to be limited to these COPD families, while there was no evidence for major gene effects in the non-pulmonary families.

References (24)

  • B.H. Cohen et al.

    Familial aggregation of chronic obstructive pulmonary disease. Epidemiologic and genetic approaches

  • F. Kueppers

    Inherited differences in alpha-lantitrypsin

  • J. Lieberman

    Heterozygous and homozygous alphalantitrypsin deficiency in patients with pulmonary emphysema

    N Engl J Med

    (1969)
  • F. Kueppers et al.

    Obstructive lung disease and α1-antitrypsin gene heterozygosity

    Science

    (1969)
  • F. Kueppers et al.

    Obstructive lung disease in heterozygotes for α1-antitrypsin deficiency

    Ann Intern Med

    (1974)
  • D.W. Cox et al.

    Protease inhibitors in patients with chronic obstructive pulmonary disease—The alpha-1-antitrypsin heterozygote controversy

    Am Rev Resp Dis

    (1976)
  • C. Mittman

    The Pi MZ phenotype: Is it a significant risk factor for the development of chronic obstructive pulmonary disease?

    Am Rev Resp Dis

    (1976)
  • A.S. Buist et al.

    Pulmonary function in heterozygotes for alpha-lantitrypsin deficiency: A case-control study

    Am Rev Resp Dis

    (1979)
  • R.M. Bruce et al.

    Collaborative study to assess risk of lung disease in PiMZ phenotype subjects

    Am Rev Resp Dis

    (1984)
  • I.B. Tager et al.

    Household aggregation of pulmonary function and chronic bronchitis

    Am Rev Resp Dis

    (1976)
  • B.H. Cohen et al.

    Risk factors in chronic obstructive pulmonary disease (COPD)

    Am J Epidemiol

    (1977)
  • B.H. Cohen

    Chronic obstructive pulmonary disease: a challenge in genetic epidemiology

    Am J Epidemiol

    (1980)
  • Cited by (0)

    View full text